Skip to search formSkip to main contentSkip to account menu

X-5079C

National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

saramycetin

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1969
1969
Assay of antifungal agent saramycetin (X-5079C) in patient body fluids.
Since the first description' of the antifungal polypeptide, saramycetin (X-5079C) 2, a series of case reports has documented its… 
1963
1963
Chemotherapeutic agents for the systemic mycoses.
DURING the past seven years there has been a sustained increase of interest in the treatment of the systemic mycoses, an interest… 
1963
1963
Factors affecting the activity of antibiotic X-5079C against Histoplasma capsulatum in vitro.
1963
1963
Observations on Mechanism of Action of the Antifungal Peptide, Ro2-7758.∗
Summary Inhibitory action of the antifungal sulfur-containing peptide, Ro2-7758 (formerly X-5079C), against the growth of Mucor… 
1962
1962
X-5079C, a new polypeptide antifungal antibiotic active against systemic mycoses.
1961
1961
Chemotherapeutic activity of X-5079C in systemic mycoses of man.
1961
1961
Chemotherapeutic studies on a new antifungal agent, X-5079C, effective against systemic mycoses.
1961
1961
Bioassay of the antifungal agent X-5079C in serum of patients.
1961
1961
Effect of the antifungal agent X-5079C on the growth of Histoplasma capsulatum in vitro.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)